Ratings by Clear Street
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 7/21/2026 | Kaveri Pohlman | Equillium | EQ | New Coverage | Buy (N/A) |
9.00 (N/A) |
2.47 (2.63) |
6.48% | Details |
| 7/20/2026 | Kaveri Pohlman | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
40.00 (29.00) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 222 more... | |||||||||
